# Shared TCR Vβ21.3+ T cell immunological signature between MIS-A and MIS-C

**Authors:** Liliane Khoryati, Signe Bech Sørensen, Christophe Parizot, Raphaëlle Lautraite, Marc Pineton de Chambrun, Andreas Ronit, Andreas Ronit, Sofie Eg Jørgensen, Casper Roed, Merete Storgaard, Ann-Britt Eg Hansen, Sarah Benezech, Samira Khaldi-Plassart, Etienne Javouhey, Guillaume Hékimian, Guy Gorochov, Trine H. Mogensen, Alexandre Belot

PMC · DOI: 10.70962/jhi.20250050 · 2026-01-08

## TL;DR

This study finds a shared T cell signature in adult and child SARS-CoV-2-related inflammatory syndromes, suggesting a common immune mechanism.

## Contribution

The study identifies a shared TCR Vβ21.3+ T cell signature in MIS-A and MIS-C, revealing a potential common immune mechanism.

## Key findings

- Vβ21.3+ T cells were expanded in 9 out of 16 MIS-A patients across two cohorts.
- Vβ21.3+ T cells showed increased activation and exhaustion markers and higher effector memory T cell abundance.
- The Vβ21.3+ T cell signature in MIS-A is similar to that previously reported in MIS-C.

## Abstract

The immune dysregulation in SARS-CoV-2–related multisystem inflammatory syndrome in adults (MIS-A) is not fully characterized. In this work, Khoryati et al. identify a T cell receptor Vβ21.3 signature in MIS-A similar to that previously reported in children (MIS-C), suggesting a shared immune-related mechanism between the two conditions.

Multisystem inflammatory syndrome (MIS) is a severe and potentially life-threatening complication of SARS-CoV-2 infection that affects both children (MIS-C) and adults (MIS-A). While the inflammatory response in MIS-C has been studied in detail, the immune dysregulation underlying MIS-A remains poorly understood, mainly due to the rarity of its condition. Using flow cytometry, we analyzed the T cell response in two, Danish and French, MIS-A cohorts, encompassing a total of 16 cases. We observed an expansion of Vβ21.3+ T cells in at least one of the major T cell subsets (CD3+, CD4+, or CD8+) in 9 out of 16 MIS-A patients. Vβ21.3+ T cells showed increased expression of activation and exhaustion markers along with a higher abundance of effector memory T cells compared to their Vβ21.3-negative counterparts in patients with or without Vβ21.3 expansion. These findings demonstrate that MIS-A shares the same Vβ21.3+ T cell signature previously reported in MIS-C, suggesting a shared pathological immune-related mechanism between the two conditions.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096), MIS-A (MONDO:0100319), MIS-C (MONDO:0100163)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}
- **Diseases:** inflammatory (MESH:D007249), MIS (MESH:C000705967), SARS-CoV-2 infection (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12871946/full.md

---
Source: https://tomesphere.com/paper/PMC12871946